Glutamic Acid Market Set for Steady Expansion, Aiming for USD 15,787.8 Million by 2033

Safety Limit Switches Market

The global glutamic acid market size is estimated to be valued at US$ 10,160.6 million in 2023. The overall demand for glutamic acid market is poised to grow at a steady CAGR of 4.7% between 2023 to 2033, totaling a market valuation of US$ 15,787.8 million by 2033.

The glutamic acid market has enormous development potential due to rising demand from end-use sectors such as animal feed, medicines, and food and beverages, among others. Another application of glutamic acid is as a flavor enhancer in processed foods, which will boost glutamic acid market expansion in the approaching years.

Request a Sample Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-3994

Consumer demand for healthier foods is propelling the worldwide glutamic acid sector forward. Glutamic acid is a food enhancer that has many health benefits. Furthermore, the public globally favors healthful diets, which increases the need for glutamic acid. Increased use of energy drinks and processed and packaged foods are important drivers driving worldwide glutamic acid market growth.

The price of glutamic acid has risen due to rising demand in the livestock nutrition and food and beverage industries.  Glutamic acid is used in the personal care and cosmetics industries to alter the pH of cosmetics and personal care products. It can be utilized in anti-aging creams, infant merchandise, eye cosmetics, hair care products, cosmetics, and bath products. It is used in anti-aging and acne lotions because of its ability to improve skin health, inhibit free radical damage, and preserve moisture.

Glutamic acid is used in pharmaceutical applications to treat a wide range of diseases in humans, including epileptic seizures, muscular atrophy, neurotransmission imbalances, and cognitive and behavioral problems, as well as to avoid nerve damage during chemotherapy. Favorable government policies supporting the pharmaceutical industry, as well as increasing private firm investment, are projected to promote the pharmaceutical industry, boosting glutamic acid usage in the coming years.

Excess glutamic acid consumption has a deleterious impact on normal health. This can result in nasal swelling, skin irritation, migraines and nausea. Additionally, a high glutamic acid intake causes allergic reactions, throat swelling, skin burning, and other health problems. These elements have an adverse effect on the glutamic acid market. However, the physician-recommended limited consumption of glutamic acid in supplement nourishment is likely to outweigh the concerns about glutamic acid’s unfavorable side effects.

Key Takeaways

  • The glutamic acid industry in the United States was predicted to hold a value share of 26% globally in 2022.
  • The glutamic acid market in the United Kingdom is projected to be expanding at a CAGR of 5.1% from 2023 to 2033.
  • During the forecast period, the market for glutamic acid in China is expected to secure a 11.4% CAGR.
  • The value share of the glutamic acid industry in Japan was estimated to reach 3.6% in 2022.
  • India’s glutamic acid industry is predicted to move forward at a 3.1% CAGR during the forecast period.

Competition in the Market

The presence of multiple established competitors in the glutamic acid market share is very competitive. To capitalize on market growth prospects, these organizations are focusing on increasing their footprint through acquisitions, expansions, product approvals, and launches.

Evonik Industries AG, KYOWA HAKKO BIO CO., LTD., Sichuan Tongsheng Amino acid Co., Ltd, Ningxia Eppen Biotech Co., Ltd, Global Bio-chem Technology Group Company Limited., Otto Chemie Pvt are the key players operating in the market.

Recent Developments

  • Iris Biotech brought out its photoaffinity labeling by diazirine building blocks suitable for the analysis of protein-protein and RNA-protein interactions in June 2023.
  • In June 2023, Bachem, a leading company in developing peptides and oligonucleotides, explained their use of Solid Phase Peptide Synthesis (SPPS).

Key Companies Profiled

  • Bio-chem Technology Group Company
  • Bachem AG
  • Ningxia EPPEN Bioengineering Stock Co., Ltd
  • Kyowa Hakko Bio Co., Ltd
  • Sichuan Tongsheng Amino Acid Co., Ltd
  • Iris Biotech GmbH
  • Suzhou Yuanfang Chemical Co. Ltd.
  • Ajinomoto Co., Inc.
  • Akzo Nobel N.V.
  • Evonik Industries AG

Purchase the Report for Key Insights: https://www.futuremarketinsights.com/checkout/3994

Key Segments Profiled in the Glutamic Acid Industry Survey

Glutamic Acid Market by Application:

  • Food additives
  • Pharmaceuticals
  • Animal & Pet Food

Glutamic Acid Market by Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact FMI:

Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *